Sökning: WFRF:(Isaksson Lars) > CD99 is a novel pro...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 06929naa a2200961 4500 | |
001 | oai:gup.ub.gu.se/165183 | |
003 | SwePub | |
008 | 240528s2012 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:075685b4-c15a-4bd4-8a53-ece6d03435a3 | |
009 | oai:DiVA.org:uu-170991 | |
009 | oai:prod.swepub.kib.ki.se:125319987 | |
024 | 7 | a https://gup.ub.gu.se/publication/1651832 URI |
024 | 7 | a https://doi.org/10.1002/ijc.275182 DOI |
024 | 7 | a https://lup.lub.lu.se/record/31895652 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1709912 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1253199872 URI |
040 | a (SwePub)gud (SwePub)lud (SwePub)uud (SwePub)ki | |
041 | a eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Edlund, Karolinau Uppsala universitet,Molekylär och morfologisk patologi4 aut0 (Swepub:uu)kaedl086 |
245 | 1 0 | a CD99 is a novel prognostic stromal marker in non-small cell lung cancer |
264 | c 2012-04-24 | |
264 | 1 | b Wiley,c 2012 |
500 | a Karolina Edlund and Cecilia Lindskog are shared first authors. | |
520 | a The complex interaction between cancer cells and the microenvironment plays an essential role in all stages of tumourigenesis. Despite the significance of this interplay, alterations in protein composition underlying tumourstroma interactions are largely unknown. The aim of this study was to identify stromal proteins with clinical relevance in non-small cell lung cancer (NSCLC). A list encompassing 203 stromal candidate genes was compiled based on gene expression array data and available literature. The protein expression of these genes in human NSCLC was screened using the Human Protein Atlas. Twelve proteins were selected that showed a differential stromal staining pattern (BGN, CD99, DCN, EMILIN1, FBN1, PDGFRB, PDLIM5, POSTN, SPARC, TAGLN, TNC and VCAN). The corresponding antibodies were applied on tissue microarrays, including 190 NSCLC samples, and stromal staining was correlated with clinical parameters. Higher stromal expression of CD99 was associated with better prognosis in the univariate (p = 0.037) and multivariate (p = 0.039) analysis. The association was independent from the proportion of tumour stroma, the fraction of inflammatory cells and clinical and pathological parameters like stage, performance status and tumour histology. The prognostic impact of stromal CD99 protein expression was confirmed in an independent cohort of 240 NSCLC patients (p = 0.008). Furthermore, double-staining confocal fluorescence microscopy showed that CD99 was expressed in stromal lymphocytes as well as in cancer-associated fibroblasts. Based on a comprehensive screening strategy the membrane protein CD99 was identified as a novel stromal factor with clinical relevance. The results support the concept that stromal properties have an important impact on tumour progression. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Klinisk laboratoriemedicin0 (SwePub)302232 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Clinical Laboratory Medicine0 (SwePub)302232 hsv//eng |
653 | a CD99 | |
653 | a CAF | |
653 | a tumour stroma | |
653 | a gene expression | |
653 | a lung cancer | |
653 | a tissue microarray | |
653 | a carcinoma-associated-fibroblasts | |
653 | a human protein atlas | |
653 | a breast-cancer | |
653 | a tumor microenvironment | |
653 | a mic2 expression | |
653 | a signature | |
653 | a growth | |
653 | a subgroups | |
653 | a molecules | |
653 | a isoforms | |
653 | a lin c | |
653 | a 1989 | |
653 | a embo journal | |
653 | a v8 | |
653 | a p3253 | |
653 | a tissue | |
653 | a microarray | |
653 | a Pathology | |
700 | 1 | a Lindskog, Ceciliau Uppsala universitet,Molekylär och morfologisk patologi4 aut0 (Swepub:uu)cecli129 |
700 | 1 | a Saito, A.4 aut |
700 | 1 | a Berglund, Andersu Uppsala universitet,Endokrinkirurgi4 aut0 (Swepub:uu)andbe182 |
700 | 1 | a Pontén, Fredriku Uppsala universitet,Molekylär och morfologisk patologi4 aut0 (Swepub:uu)fredpont |
700 | 1 | a Goransson-Kultima, H.u Uppsala universitet,Institutionen för medicinska vetenskaper,Onkologisk farmakologi och informatik4 aut |
700 | 1 | a Isaksson, A.4 aut |
700 | 1 | a Jirström, Karinu Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)pat-kji |
700 | 1 | a Planck, M.4 aut |
700 | 1 | a Johansson, Leifu Lund University,Lunds universitet,Tumörmikromiljö,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Tumor microenvironment,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine4 aut0 (Swepub:lu)pat-ljo |
700 | 1 | a Lambe, M.u Karolinska Institutet4 aut |
700 | 1 | a Holmberg, Larsu Uppsala universitet,Endokrinkirurgi4 aut0 (Swepub:uu)larsholmb |
700 | 1 | a Nyberg, Fredrik,d 1961u Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för samhällsmedicin och folkhälsa,Institute of Medicine, School of Public Health and Community Medicine4 aut0 (Swepub:gu)xnybef |
700 | 1 | a Ekman, Simonu Uppsala universitet,Enheten för onkologi4 aut0 (Swepub:uu)simoekma |
700 | 1 | a Bergqvist, Michaelu Uppsala universitet,Enheten för onkologi4 aut0 (Swepub:uu)michberg |
700 | 1 | a Landelius, Peru Uppsala universitet,Thoraxkirurgi4 aut0 (Swepub:uu)perla667 |
700 | 1 | a Lamberg, Kristinau Uppsala universitet,Lungmedicin och allergologi4 aut0 (Swepub:uu)krila642 |
700 | 1 | a Botling, Johanu Uppsala universitet,Molekylär och morfologisk patologi4 aut0 (Swepub:uu)johanbot |
700 | 1 | a Ostman, A.u Karolinska Institutet4 aut |
700 | 1 | a Micke, Patricku Uppsala universitet,Molekylär och morfologisk patologi4 aut0 (Swepub:uu)patmi676 |
710 | 2 | a Uppsala universitetb Molekylär och morfologisk patologi4 org |
773 | 0 | t International Journal of Cancerd : Wileyg 131:10, s. 2264-2273q 131:10<2264-2273x 0020-7136x 1097-0215 |
856 | 4 | u http://dx.doi.org/10.1002/ijc.27518y FULLTEXT |
856 | 4 | u https://doi.org/10.1002/ijc.27518y Fulltext |
856 | 4 8 | u https://gup.ub.gu.se/publication/165183 |
856 | 4 8 | u https://doi.org/10.1002/ijc.27518 |
856 | 4 8 | u https://lup.lub.lu.se/record/3189565 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-170991 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:125319987 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.